Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Lipocine Inc. (LPCN)
USD2.36
+0.05 (+2.16%)
US NASDAQ Healthcare Biotechnology
Address
675 Arapeen Drive 84108
Salt Lake City, UT, US
Salt Lake City, UT, US
CEO
Mahesh V. Patel
Website
lipocine.com
IPO
2013-10-22
CIK 1535955 ISIN US53630X2036
Description
Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic conditions. A core aspect of the company's research and development involves formulating oral delivery methods for pharmaceutical compounds that typically suffer from low bioavailability. Its foremost investigational therapy is TLANDO, an oral solution for testosterone replacement. The company's development pipeline also encompasses several other promising candidates: LPCN 1144: An orally administered prodrug derived from bioidentical testosterone, which has successfully completed Phase II clinical trials for the treatment of non-cirrhotic non-alcoholic steatohepatitis. LPCN 1111: An oral prodrug of testosterone tridecanoate, engineered for once-daily administration, and having also concluded Phase II clinical studies in men experiencing hypogonadism. LPCN 1148: A novel prodrug combining testosterone and testosterone laurate, designed for the management of decompensated cirrhosis. LPCN 1154: An investigational new drug application has been submitted to initiate a Phase 2 study targeting Postpartum Depression. LPCN 2101: A compound intended for women with epilepsy, which has progressed beyond its pre-clinical study phase. LPCN 1107: An oral hydroxyprogesterone caproate product, which has completed its dose-finding Phase II clinical trial aimed at preventing recurrent preterm birth. The corporate headquarters for Lipocine Inc. are located in Salt Lake City, Utah.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.36
+0.05 (+2.16%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
283.3K
Beta
0.46
Float Shares
5.29M
Free Float %
97.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.43% | -2.10% | +5.91% | -73.13% | -20.21% | -70.98% | -20.21% | -45.94% | -89.46% | -98.21% | -98.63% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (9 ratings, all time)
Buy
Price Targets & DCF
Current price
2.36
Low
6.00
+154.2%
Consensus
10.50
+344.9%
Median
10.50
+344.9%
High
15.00
+535.6%
DCF (Unlevered)
0.75
-68.2%
DCF (Levered)
0.91
-61.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | -1 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
6.00
+154.2%
|
| Last Quarter | 1 |
6.00
+154.2%
|
| Last Year | 2 |
10.50
+344.9%
|
| All Time | 3 |
10.33
+337.7%
|
Quality scores
Altman Z-Score
-9.15
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-82.4% Q1'26: +27.2% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-105,525.0% Q1'26: -54.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-533.9% Q1'26: -1,890.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-524.7% Q1'26: -3,224.1% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +810.9% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+5.3% Q1'26: +27.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
428.0K
est: 418.7K (+2.2%)
|
165.0K
est: 200.0K (-17.5%)
|
16.14M
est: 3.75M (+330.2%)
|
500.0K
est: 1.81M (-72.3%)
|
-2.85M
est: 4.80M (-159.4%)
|
11.20M
est: 10.32M (+8.5%)
|
1.98M
est: 947.0K (+108.7%)
|
588.0K
519.3K – 656.7K
-37.9% YoY
|
1.09M
962.7K – 1.22M
+85.4% YoY
|
1.20M
1.06M – 1.34M
+10.1% YoY
|
2.89M
2.55M – 3.23M
+141.0% YoY
|
9.39M
8.29M – 10.48M
+224.6% YoY
|
| EBITDA |
-11.31M
est: 73.2K (-15,553.4%)
|
-12.22M
est: 35.0K (-35,074.4%)
|
-430.5K
est: 655.7K (-165.7%)
|
-10.72M
est: 315.6K (-3,496.8%)
|
-17.90M
est: -1.08M (-1,555.6%)
|
-1.11M
est: -2.32M (+52.1%)
|
-10.31M
est: -213.3K (-4,734.0%)
|
-132.4K
-147.9K – -117.0K
+37.9% YoY
|
-245.5K
-274.2K – -216.8K
-85.4% YoY
|
-270.3K
-301.8K – -238.7K
-10.1% YoY
|
-651.3K
-727.3K – -575.2K
-141.0% YoY
|
-2.11M
-2.36M – -1.87M
-224.6% YoY
|
| EBIT |
-11.33M
est: 72.9K (-15,644.4%)
|
-12.24M
est: 34.8K (-35,267.5%)
|
-430.9K
est: 652.9K (-166.0%)
|
-10.73M
est: 314.3K (-3,514.2%)
|
-17.93M
est: -1.08M (-1,552.8%)
|
-1.16M
est: -2.33M (+50.5%)
|
-10.37M
est: -214.0K (-4,746.6%)
|
-132.9K
-148.4K – -117.3K
+37.9% YoY
|
-246.3K
-275.1K – -217.5K
-85.4% YoY
|
-271.2K
-302.8K – -239.5K
-10.1% YoY
|
-653.4K
-729.7K – -577.1K
-141.0% YoY
|
-2.12M
-2.37M – -1.87M
-224.6% YoY
|
| Net Income |
-11.66M
est: -48.86M (+76.1%)
|
-13.01M
est: -46.09M (+71.8%)
|
-634.4K
est: -13.52M (+95.3%)
|
-10.76M
est: -12.06M (+10.8%)
|
-16.35M
est: -8.49M (-92.6%)
|
8.4K
est: -4.51M (+100.2%)
|
-9.63M
est: -11.43M (+15.8%)
|
-10.87M
-12.53M – -9.22M
+4.9% YoY
|
-9.42M
-10.85M – -7.99M
+13.4% YoY
|
-5.42M
-6.25M – -4.60M
+42.4% YoY
|
-4.28M
-4.93M – -3.63M
+21.1% YoY
|
-2.00M
-2.30M – -1.69M
+53.3% YoY
|
| SGA |
5.29M
est: 685.0K (+672.1%)
|
5.60M
est: 327.3K (+1,610.3%)
|
5.33M
est: 6.14M (-13.2%)
|
4.06M
est: 2.96M (+37.5%)
|
4.90M
est: 8.72M (-43.8%)
|
5.00M
est: 18.75M (-73.3%)
|
3.76M
est: 1.72M (+118.7%)
|
1.07M
943.6K – 1.19M
-37.9% YoY
|
1.98M
1.75M – 2.21M
+85.4% YoY
|
2.18M
1.93M – 2.44M
+10.1% YoY
|
5.25M
4.64M – 5.87M
+141.0% YoY
|
17.06M
15.06M – 19.05M
+224.6% YoY
|
| EPS |
-9.35
est: -9.01 (-3.8%)
|
-8.54
est: -8.50 (-0.5%)
|
-0.19
est: -2.49 (+92.4%)
|
-2.15
est: -2.15 (+0.2%)
|
-3.14
est: -1.60 (-96.7%)
|
0.00
est: -0.73 (+100.2%)
|
-1.77
est: -1.97 (+9.9%)
|
-1.91
-2.19 – -1.62
+3.1% YoY
|
-1.65
-1.90 – -1.40
+13.4% YoY
|
-0.95
-1.09 – -0.81
+42.4% YoY
|
-0.75
-0.86 – -0.64
+21.1% YoY
|
-0.35
-0.40 – -0.30
+53.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-7.89M
OE per share TTM
-1.43
Owner's Yield
-48.60%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
1.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
7
Total invested
2.16M
Insider transactions (90d)
0
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group - 23-1945930 | 3.81M | 4.32% | — | 12.7K | 3.77M | 41.4K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 2 | Mr. Philip C. Timon | 2.83M | 14.60% | — | 3.36M | — | 3.36M | IN | Cayman Islands | 2020-02-25 | ↗ |
| 3 | 2 | 1.21M | 10.90% | — | 1.21M | — | 1.21M | HC, OO | Cayman Islands | 2013-11-22 | ↗ |
| 4 | JG Asset, LLC | 1.21M | 9.90% | — | 1.21M | — | — | HC | Cayman Islands | 2013-08-05 | ↗ |
| 5 | Jacob Gottlieb | 1.21M | 9.90% | — | 1.21M | — | — | HC, IN | Cayman Islands | 2013-08-05 | ↗ |
| 6 | LP | 1.21M | 9.90% | — | 1.21M | — | — | IA | Cayman Islands | 2013-08-05 | ↗ |
| 7 | Ltd. | 1.21M | 9.90% | — | 1.21M | — | — | CO | Cayman Islands | 2013-08-05 | ↗ |
| 8 | Koh, Bong | 1.17M | 5.50% | — | 1.17M | — | — | IN | United States | 2018-02-14 | ↗ |
| 9 | Shah, Nimish | 1.17M | 5.50% | — | 1.17M | — | — | IN | United States | 2018-02-14 | ↗ |
| 10 | VHCP Co-Investment Holdings II, LLC | 1.17M | 5.50% | — | 1.17M | — | — | OO | Delaware | 2018-02-14 | ↗ |
| 11 | VHCP Co-Investment Holdings, LLC | 1.17M | 5.50% | — | 1.17M | — | — | OO | Delaware | 2018-02-14 | ↗ |
| 12 | VHCP Management II, LLC | 1.17M | 5.50% | — | 1.17M | — | — | OO | Delaware | 2018-02-14 | ↗ |
| 13 | VHCP Management, LLC | 1.17M | 5.50% | — | 1.17M | — | — | OO | Delaware | 2018-02-14 | ↗ |
| 14 | Venrock Healthcare Capital Partners II, L.P. | 1.17M | 5.50% | — | 1.17M | — | — | PN | Delaware | 2018-02-14 | ↗ |
| 15 | Venrock Healthcare Capital Partners, L.P. | 1.17M | 5.50% | — | 1.17M | — | — | PN | Delaware | 2018-02-14 | ↗ |
| 16 | Sabby Healthcare Master Fund, Ltd. | 1.00M | 5.71% | — | 1.00M | — | 1.00M | CO | Cayman Islands | 2015-04-29 | ↗ |
| 17 | (1) BlackRock, Inc. | 958.4K | 4.97% | 933.1K | — | 958.4K | — | HC | Delaware | 2017-06-08 | ↗ |
| 18 | First Bank System Inc. | 216.0K | 10.89% | — | 3.10M | — | 3.10M | HC | Cayman Islands | 2019-11-22 | ↗ |
| 19 | 52-2343049 | 142.2K | 0.67% | 142.2K | — | 142.2K | — | IA | New York | 2018-01-03 | ↗ |
| 20 | 13-3127734 | — | 0.00% | — | — | — | — | HC | Delaware | 2021-02-11 | ↗ |
| 21 | 26-0385758 | — | 0.00% | — | — | — | — | IA | Delaware | 2021-02-11 | ↗ |
| 22 | 98-0557567 | — | 0.00% | — | — | — | — | IA, HC | Bermuda | 2018-02-06 | ↗ |
| 23 | Hudson Bay Capital Management LP | — | 0.00% | — | — | — | — | PN | State of Delaware | 2021-02-10 | ↗ |
| 24 | Sander Gerber | — | 0.00% | — | — | — | — | IN | United States | 2021-02-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
7
-19 vs prev Q
New positions
4
Closed positions
23
Increased
4
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 530.0K +530.0K (+100.0%) | 4.26M +4.3M (+100.0%) | 9.79% +9.791 pp | 1.80% +1.804 pp | USD8.03 +0.0% | 1 qtrs NEW |
| 2 | DIADEMA PARTNERS LP | 260.9K +260.9K (+100.0%) | 2.10M +2.1M (+100.0%) | 4.82% +4.821 pp | 0.36% +0.361 pp | USD8.03 +0.0% | 1 qtrs NEW |
| 3 | VANGUARD GROUP INC | 221.9K +— (+0.0%) | 1.78M +1.1M (+180.8%) | 4.10% -0.047 pp | 0.00% +0.000 pp | USD5.00 +60.6% | 11 qtrs — |
| 4 | IKARIAN CAPITAL, LLC | 199.5K +199.5K (+100.0%) | 1.60M +1.6M (+100.0%) | 3.69% +3.686 pp | 0.13% +0.125 pp | USD8.03 +0.0% | 1 qtrs NEW |
| 5 | BLACKROCK, INC. | 89.3K +— (+0.0%) | 716.9K +462.4K (+181.8%) | 1.65% -0.019 pp | 0.00% +0.000 pp | USD4.49 +78.8% | 6 qtrs — |
| 6 | PERSISTENT ASSET PARTNERS LTD | 70.6K +70.6K (+100.0%) | 566.7K +566.7K (+100.0%) | 1.30% +1.304 pp | 0.25% +0.255 pp | USD8.03 +0.0% | 1 qtrs NEW |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 62.5K +1.4K (+2.2%) | 501.5K +326.8K (+187.1%) | 1.15% +0.013 pp | 0.00% +0.000 pp | USD5.16 +55.6% | 11 qtrs — |
| 8 | BOOTHBAY FUND MANAGEMENT, LLC | 54.9K +54.9K (+100.0%) | 440.8K +440.8K (+100.0%) | 1.01% +1.014 pp | 0.01% +0.007 pp | USD8.03 +0.0% | 1 qtrs NEW |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 37.4K +1.3K (+3.6%) | 300.3K +197.4K (+191.9%) | 0.69% +0.016 pp | 0.00% +0.000 pp | USD4.71 +70.5% | 11 qtrs — |
| 10 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 24.9K -21.9K (-46.7%) | 200.0K +66.3K (+49.6%) | 0.46% -0.414 pp | 0.00% +0.000 pp | USD3.28 +144.8% | 11 qtrs — |
| 11 | STATE STREET CORP | 18.6K +— (+0.0%) | 149.6K +96.3K (+180.8%) | 0.34% -0.004 pp | 0.00% +0.000 pp | USD5.04 +59.3% | 11 qtrs — |
| 12 | AMERIPRISE FINANCIAL INC | 16.1K +16.1K (+100.0%) | 129.3K +129.3K (+100.0%) | 0.30% +0.298 pp | 0.00% +0.000 pp | USD8.03 +0.0% | 1 qtrs NEW |
| 13 | NORTHERN TRUST CORP | 13.2K +— (+0.0%) | 105.7K +68.2K (+181.8%) | 0.24% -0.003 pp | 0.00% +0.000 pp | USD7.72 +4.0% | 7 qtrs — |
| 14 | DIMENSIONAL FUND ADVISORS LP | 12.1K +— (+0.0%) | 97.5K +62.8K (+180.8%) | 0.22% -0.003 pp | 0.00% +0.000 pp | USD5.83 +37.7% | 7 qtrs — |
| 15 | JANE STREET GROUP, LLC | 10.6K +10.6K (+100.0%) | 84.9K +84.9K (+100.0%) | 0.20% +0.195 pp | 0.00% +0.000 pp | USD8.03 +0.0% | 1 qtrs NEW |
| 16 | UBS GROUP AG | 5.6K +3.8K (+217.3%) | 45.0K +40.0K (+793.8%) | 0.10% +0.071 pp | 0.00% +0.000 pp | USD6.43 +24.9% | 10 qtrs — |
| 17 | MORGAN STANLEY | 751.00 +176.0 (+30.6%) | 6.0K +4.4K (+268.0%) | 0.01% +0.003 pp | 0.00% +0.000 pp | USD7.23 +11.1% | 11 qtrs — |
| 18 | CALDWELL SUTTER CAPITAL, INC. | 471.00 +— (+0.0%) | 3.8K +2.4K (+181.8%) | 0.01% 0.000 pp | 0.00% +0.001 pp | USD5.04 +59.3% | 11 qtrs — |
| 19 | GROUP ONE TRADING, L.P. | 162.00 +— (+0.0%) | 1.3K +838.0 (+181.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.51 +78.0% | 11 qtrs — |
| 20 | ROYAL BANK OF CANADA | 73.00 +73.0 (+100.0%) | 1.0K +1.0K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD8.03 +0.0% | 1 qtrs NEW |
| 21 | ADVISOR GROUP HOLDINGS, INC. | 118.00 -2.2K (-94.8%) | 947.00 -5.5K (-85.3%) | 0.00% -0.040 pp | 0.00% +0.000 pp | USD3.54 +126.8% | 11 qtrs — |
| 22 | HIGHMARK WEALTH MANAGEMENT LLC | 100.00 +100.0 (+100.0%) | 803.00 +803.0 (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD8.02 +0.1% | 1 qtrs NEW |
| 23 | FMR LLC | 77.00 +18.0 (+30.5%) | 618.00 +449.0 (+265.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.05 +98.3% | 5 qtrs — |
| 24 | SBI SECURITIES CO., LTD. | 67.00 +— (+0.0%) | 538.00 +347.0 (+181.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.18 +152.5% | 4 qtrs — |
| 25 | TIDEMARK, LLC | 59.00 +— (+0.0%) | 474.00 +306.0 (+182.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.17 +153.3% | 9 qtrs — |
| 26 | BANK OF AMERICA CORP /DE/ | 52.00 +3.0 (+6.1%) | 417.00 +278.0 (+200.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.54 +126.8% | 11 qtrs — |
| 27 | BARCLAYS PLC | — -9.4K (-100.0%) | — -26.8K (-100.0%) | 0.00% -0.176 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 28 | TOWER RESEARCH CAPITAL LLC (TRC) | — -1.2K (-100.0%) | — -3.3K (-100.0%) | 0.00% -0.022 pp | 0.00% 0.000 pp | USD— | 11 qtrs SOLD |
| 29 | CITADEL ADVISORS LLC | — -14.2K (-100.0%) | — -40.7K (-100.0%) | 0.00% -0.266 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 30 | CITIGROUP INC | — -3.0 (-100.0%) | — -9.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 15 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - US Core Equity 1 ETF DCOR | 0.00% | 12.7K | 0.14% |
| 2 | U.S. Micro Cap Portfolio ETF DFMC | 0.00% | 12.7K | 0.43% |
| 3 | Vanguard Extended Market ETF VXF | 0.00% | 127.3K | 0.05% |
| 4 | Dimensional - US Small Cap ETF DFAS | 0.00% | 14.9K | 0.26% |
| 5 | Dimensional - US Core Equity 2 ETF DFAC | 0.00% | 11.8K | 0.17% |
| 6 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 138.09 | 0.17% |
| 7 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 680.88 | 0.03% |
| 8 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 1.9K | 0.17% |
| 9 | Vanguard Total Stock Market ETF VTI | 0.00% | 319.5K | 0.03% |
| 10 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 700.20 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
3
Sells
0
Shares acquired
173.0K
Shares disposed
—
Cash buys
3.00
Cash sales
—
Net activity
+173,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-07 | Higuchi John W. | Director | P-Purchase | A | Common stock | 40,000 | 2.03 | 81.2K | 203,797 | D | ↗ |
| 2026-04-06 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common stock | 25,000 | 2.03 | 50.8K | 160,679 | D | ↗ |
| 2026-04-06 | Higuchi John W. | Director | P-Purchase | A | Common stock | 123,000 | 2.05 | 252.2K | 163,797 | D | ↗ |
| 2026-04-02 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common stock | 25,000 | 2.02 | 50.5K | 135,679 | D | ↗ |
| 2026-01-02 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 8.00 | 200.0K | 182,668 | D | ↗ |
| 2025-12-18 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 8,629 | 4.20 | 36.2K | 157,668 | D | ↗ |
| 2025-12-18 | Fogarty Krista | Officer | A-Award | A | Stock Option (Right to Buy) | 20,786 | 4.20 | 87.3K | 40,146 | D | ↗ |
| 2025-06-04 | Papapetropoulos Spyros | Director | A-Award | A | Stock Option (Right to Buy) | 1,764 | 3.20 | 5.6K | 7,174 | D | ↗ |
| 2025-06-04 | Ono Richard Dana | Director | A-Award | A | Common Stock (Right to Buy) | 1,764 | 3.20 | 5.6K | 11,526 | D | ↗ |
| 2025-06-04 | Jene Jill M. | Director | A-Award | A | Stock Option (Right to Buy) | 1,764 | 3.20 | 5.6K | 7,174 | D | ↗ |
| 2025-06-04 | Higuchi John W. | Director | A-Award | A | Common Stock (Right to Buy) | 1,764 | 3.20 | 5.6K | 11,526 | D | ↗ |
| 2025-06-04 | Fink Jeffrey Arvin | Director | A-Award | A | Common Stock (Right to Buy) | 1,764 | 3.20 | 5.6K | 11,526 | D | ↗ |
| 2025-01-02 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 16,371 | 4.86 | 79.6K | 149,039 | D | ↗ |
| 2024-12-23 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 26,691 | 4.80 | 128.1K | 149,039 | D | ↗ |
| 2024-12-23 | Fogarty Krista | Officer | A-Award | A | Stock Option (Right to Buy) | 5,943 | 4.80 | 28.5K | 19,460 | D | ↗ |
| 2024-06-05 | Papapetropoulos Spyros | Director | A-Award | A | Stock Option (Right to Buy) | 1,764 | 7.05 | 12.4K | 5,410 | — | ↗ |
| 2024-06-05 | Ono Richard Dana | Director | A-Award | A | Common Stock (Right to Buy) | 1,764 | 7.05 | 12.4K | 10,938 | — | ↗ |
| 2024-06-05 | Jene Jill M. | Director | A-Award | A | Stock Option (Right to Buy) | 1,764 | 7.05 | 12.4K | 5,410 | — | ↗ |
| 2024-06-05 | Higuchi John W. | Director | A-Award | A | Common Stock (Right to Buy) | 1,764 | 7.05 | 12.4K | 10,938 | — | ↗ |
| 2024-06-05 | Fink Jeffrey Arvin | Director | A-Award | A | Common Stock (Right to Buy) | 1,764 | 7.05 | 12.4K | 10,938 | — | ↗ |
| 2024-03-08 | Patel Mahesh V. | Director / Officer | A-Award | A | Common Stock | 4,893 | 0.00 | — | 112,311 | — | ↗ |
| 2024-03-08 | Fogarty Krista | Officer | A-Award | A | Common Stock | 991 | 0.00 | — | 1,727 | — | ↗ |
| 2023-05-25 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 8,706 | 5.03 | 43.8K | 107,418 | — | ↗ |
| 2023-05-10 | Papapetropoulos Spyros | Director | A-Award | A | Stock Option (Right to Buy) | 30,000 | 0.27 | 8.0K | 62,000 | — | ↗ |
| 2023-05-10 | Ono Richard Dana | Director | A-Award | A | Common Stock (Right to Buy) | 30,000 | 0.27 | 8.0K | 166,000 | — | ↗ |
| 2023-05-10 | Jene Jill M. | Director | A-Award | A | Stock Option (Right to Buy) | 30,000 | 0.27 | 8.0K | 62,000 | — | ↗ |
| 2023-05-10 | Higuchi John W. | Director | A-Award | A | Common Stock (Right to Buy) | 30,000 | 0.27 | 8.0K | 156,000 | — | ↗ |
| 2023-05-10 | Fink Jeffrey Arvin | Director | A-Award | A | Common Stock (Right to Buy) | 30,000 | 0.27 | 8.0K | 166,000 | — | ↗ |
| 2023-03-24 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 150,000 | 0.32 | 48.0K | 1,678,090 | — | ↗ |
| 2023-03-20 | Ono Richard Dana | Director | P-Purchase | A | Common Stock | 4,000 | 0.34 | 1.4K | 14,125 | — | ↗ |
| 2023-03-17 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.33 | 16.5K | 1,528,090 | — | ↗ |
| 2023-01-03 | Patel Mahesh V. | Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 0.41 | 123.0K | 2,542,395 | — | ↗ |
| 2022-12-22 | Patel Mahesh V. | Officer | A-Award | A | Stock Option (Right to Buy) | 112,500 | 0.41 | 46.1K | 2,242,395 | — | ↗ |
| 2022-12-22 | Fogarty Krista | Officer | A-Award | A | Stock Option (Right to Buy) | 91,850 | 0.41 | 37.7K | 229,850 | — | ↗ |
| 2022-12-07 | Fogarty Krista | Officer | — | D | Stock Option (Right to Buy) | 46,000 | 1.12 | 51.5K | 0 | — | ↗ |
| 2022-11-22 | Papapetropoulos Spyros | Director | P-Purchase | A | Common stock | 21,739 | 0.47 | 10.2K | 21,739 | — | ↗ |
| 2022-11-14 | Patel Mahesh V. | Officer | P-Purchase | A | Common Stock | 75,000 | 0.39 | 29.3K | 1,478,090 | — | ↗ |
| 2022-11-01 | Nomikos George | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 0.41 | 50.8K | 125,000 | — | ↗ |
| 2022-09-27 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 100,000 | 0.41 | 41.0K | 1,403,090 | — | ↗ |
| 2022-06-08 | Papapetropoulos Spyros | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 0.92 | 20.2K | 32,000 | — | ↗ |
| 2022-06-08 | Ono Richard Dana | Director | A-Award | A | Common Stock (Right to Buy) | 22,000 | 0.92 | 20.2K | 136,000 | — | ↗ |
| 2022-06-08 | Jene Jill M. | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 0.92 | 20.2K | 32,000 | — | ↗ |
| 2022-06-08 | Higuchi John W. | Director | A-Award | A | Common Stock (Right to Buy) | 22,000 | 0.92 | 20.2K | 307,490 | — | ↗ |
| 2022-06-08 | Fink Jeffrey Arvin | Director | A-Award | A | Common Stock (Right to Buy) | 22,000 | 0.92 | 20.2K | 136,000 | — | ↗ |
| 2022-05-17 | Fogarty Krista | Officer | P-Purchase | A | Common Stock | 12,500 | 0.86 | 10.8K | 12,500 | — | ↗ |
| 2022-05-16 | Patel Mahesh V. | Officer | P-Purchase | A | Common Stock | 50,000 | 0.77 | 38.5K | 1,303,090 | — | ↗ |
| 2022-04-11 | Papapetropoulos Spyros | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.16 | 11.6K | 10,000 | — | ↗ |
| 2022-04-11 | Jene Jill M. | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.16 | 11.6K | 10,000 | — | ↗ |
| 2022-01-03 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 287,500 | 1.09 | 313.4K | 287,500 | — | ↗ |
| 2021-12-15 | Fogarty Krista | Officer | — | D | Stock Option (Right to Buy) | 46,000 | 1.37 | 63.0K | 0 | — | ↗ |
| 2021-12-07 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 1.12 | 140.0K | 125,000 | — | ↗ |
| 2021-12-07 | BROWN MORGAN R | Officer | A-Award | A | Stock Option (Right to Buy) | 176,000 | 1.12 | 197.1K | 176,000 | — | ↗ |
| 2021-11-18 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 1.09 | 27.3K | 1,253,090 | — | ↗ |
| 2021-06-09 | Ono Richard Dana | Director | A-Award | A | Common Stock (Right to Buy) | 22,000 | 1.26 | 27.7K | 22,000 | — | ↗ |
| 2021-06-09 | Higuchi John W. | Director | A-Award | A | Common Stock (Right to Buy) | 22,000 | 1.26 | 27.7K | 22,000 | — | ↗ |
| 2021-06-09 | Fink Jeffrey Arvin | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 1.26 | 27.7K | 22,000 | — | ↗ |
| 2021-01-28 | Fogarty Krista | Officer | — | D | Stock Option (Right to Buy) | 26,000 | 0.46 | 11.9K | 0 | — | ↗ |
| 2021-01-04 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 275,000 | 1.43 | 393.3K | 275,000 | — | ↗ |
| 2020-12-31 | Higuchi John W. | Director | S-Sale | D | Common Stock | 1,700 | 1.35 | 2.3K | 698,548 | — | ↗ |
| 2020-12-28 | Patel Mahesh V. | Director / Officer | J-Other | D | Stock Option (Right to Buy) | 275,000 | 1.37 | 376.8K | 100,000 | — | ↗ |
| 2020-12-16 | Patel Mahesh V. | Director / Officer | M-Exempt | A | Restricted Stock Unit | 45,000 | 0.00 | — | 45,000 | — | ↗ |
| 2020-12-16 | Ono Richard Dana | Director | M-Exempt | A | Restricted Stock Unit | 5,250 | 0.00 | — | 5,250 | — | ↗ |
| 2020-12-16 | Higuchi John W. | Director | M-Exempt | A | Restricted Stock Unit | 3,750 | 0.00 | — | 3,750 | — | ↗ |
| 2020-12-16 | HILL STEPHEN A | Director | M-Exempt | A | Common Stock | 7,500 | 0.00 | — | 12,750 | — | ↗ |
| 2020-12-16 | Fink Jeffrey Arvin | Director | M-Exempt | A | Common Stock | 5,625 | 0.00 | — | 6,562 | — | ↗ |
| 2020-12-16 | BROWN MORGAN R | Officer | S-Sale | D | Common Stock | 8,437 | 1.35 | 11.4K | 194,504 | — | ↗ |
| 2020-12-15 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 375,000 | 1.37 | 513.8K | 375,000 | — | ↗ |
| 2020-12-15 | BROWN MORGAN R | Officer | A-Award | A | Stock Options (Right to Buy) | 160,000 | 1.37 | 219.2K | 160,000 | — | ↗ |
| 2020-12-05 | Patel Mahesh V. | Director / Officer | M-Exempt | D | Restricted Stock Unit | 122,978 | 0.00 | — | 122,978 | — | ↗ |
| 2020-12-05 | BROWN MORGAN R | Officer | M-Exempt | D | Restricted Stock Unit | 70,754 | 0.00 | — | 70,754 | — | ↗ |
| 2020-12-04 | Patel Mahesh V. | Director / Officer | M-Exempt | D | Restricted Stock Unit | 145,000 | 0.00 | — | 145,000 | — | ↗ |
| 2020-12-04 | BROWN MORGAN R | Officer | M-Exempt | D | Restricted Stock Unit | 57,500 | 0.00 | — | 57,500 | — | ↗ |
| 2020-06-10 | Ono Richard Dana | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 0.96 | 21.2K | 22,000 | — | ↗ |
| 2020-06-10 | Higuchi John W. | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 0.96 | 21.2K | 22,000 | — | ↗ |
| 2020-06-10 | HILL STEPHEN A | Director | A-Award | A | Stock Options (Right to Buy) | 22,000 | 0.96 | 21.2K | 22,000 | — | ↗ |
| 2020-06-10 | Fink Jeffrey Arvin | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 0.96 | 21.2K | 22,000 | — | ↗ |
| 2020-03-17 | Higuchi John W. | Director | P-Purchase | A | Common Stock | 220,000 | 0.32 | 69.5K | 696,498 | — | ↗ |
| 2020-01-28 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 0.46 | 137.4K | 300,000 | — | ↗ |
| 2020-01-28 | BROWN MORGAN R | Officer | A-Award | A | Stock Option (Right to Buy) | 132,000 | 0.46 | 60.5K | 132,000 | — | ↗ |
| 2019-12-31 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 40,000 | 0.38 | 15.3K | 973,612 | — | ↗ |
| 2019-12-10 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.40 | 10.0K | 933,612 | — | ↗ |
| 2019-12-05 | Patel Mahesh V. | Director / Officer | A-Award | A | Restricted Stock Unit | 122,978 | 0.00 | — | 122,978 | — | ↗ |
| 2019-12-05 | BROWN MORGAN R | Officer | A-Award | A | Restricted Stock Unit | 70,754 | 0.00 | — | 70,754 | — | ↗ |
| 2019-12-04 | Patel Mahesh V. | Director / Officer | M-Exempt | D | Restricted Stock Unit | 145,000 | 0.00 | — | 145,000 | — | ↗ |
| 2019-12-04 | Fogarty Krista | Officer | — | D | Stock Option (Right to Buy) | 5,000 | 1.46 | 7.3K | 0 | — | ↗ |
| 2019-12-04 | BROWN MORGAN R | Officer | M-Exempt | D | Restricted Stock Unit | 57,500 | 0.00 | — | 57,500 | — | ↗ |
| 2019-11-26 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 21,928 | 0.43 | 9.4K | 807,112 | — | ↗ |
| 2019-11-18 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 4,810 | 0.42 | 2.0K | 782,112 | — | ↗ |
| 2019-10-22 | Fogarty Krista | Officer | — | D | Stock Option (Right to Buy) | 15,000 | 1.13 | 17.0K | 0 | — | ↗ |
| 2019-06-12 | Ono Richard Dana | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.68 | 16.8K | 10,000 | — | ↗ |
| 2019-06-12 | Higuchi John W. | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.68 | 16.8K | 10,000 | — | ↗ |
| 2019-06-12 | HILL STEPHEN A | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.68 | 16.8K | 10,000 | — | ↗ |
| 2019-06-12 | Fink Jeffrey Arvin | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.68 | 16.8K | 10,000 | — | ↗ |
| 2019-05-24 | Patel Mahesh V. | Director / Officer | A-Award | A | Common Stock | 2,500 | 1.64 | 4.1K | 732,112 | — | ↗ |
| 2018-12-04 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 1.46 | 219.0K | 150,000 | — | ↗ |
| 2018-12-04 | BROWN MORGAN R | Officer | A-Award | A | Stock Option (Right to buy) | 75,000 | 1.46 | 109.5K | 75,000 | — | ↗ |
| 2018-06-27 | Ono Richard Dana | Director | A-Award | A | Stcck Optoin (right to buy) | 20,000 | 1.33 | 26.6K | 20,000 | — | ↗ |
| 2018-06-27 | Higuchi John W. | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 1.33 | 26.6K | 20,000 | — | ↗ |
| 2018-06-27 | HILL STEPHEN A | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 1.33 | 26.6K | 20,000 | — | ↗ |
| 2018-06-27 | Fink Jeffrey Arvin | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 1.33 | 26.6K | 20,000 | — | ↗ |
| 2017-12-31 | Bass Gregory Brooks | Officer | — | D | Restricted Stock Unit | 37,500 | 0.00 | — | 0 | — | ↗ |
| 2017-12-29 | Patel Mahesh V. | Director / Officer | S-Sale | D | Common stock | 6,000 | 3.48 | 20.9K | 722,112 | — | ↗ |
| 2017-12-29 | Ono Richard Dana | Director | M-Exempt | D | Restricted Stock Unit | 1,750 | 0.00 | — | 5,250 | — | ↗ |
| 2017-12-29 | Higuchi John W. | Director | M-Exempt | D | Restricted stock units | 1,250 | 0.00 | — | 3,750 | — | ↗ |
| 2017-12-29 | HILL STEPHEN A | Director | M-Exempt | A | Common Stock | 2,500 | 0.00 | — | 6,500 | — | ↗ |
| 2017-12-29 | Fink Jeffrey Arvin | Director | M-Exempt | D | Restricted Stock Unit | 1,875 | 0.00 | — | 5,625 | — | ↗ |
| 2017-12-29 | Bass Gregory Brooks | Officer | M-Exempt | A | Common Stock | 9,375 | 0.00 | — | 9,375 | — | ↗ |
| 2017-12-29 | BROWN MORGAN R | Officer | M-Exempt | A | Common Stock | 9,375 | 0.00 | — | 26,375 | — | ↗ |
| 2017-12-07 | Bass Gregory Brooks | Officer | — | D | Stock Option (Right to Buy) | 35,000 | 3.61 | 126.4K | 0 | — | ↗ |
| 2017-12-06 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 150,000 | 3.52 | 528.0K | 150,000 | — | ↗ |
| 2017-12-06 | Bass Gregory Brooks | Officer | A-Award | A | Stock Options (Right to Buy) | 75,000 | 3.52 | 264.0K | 75,000 | — | ↗ |
| 2017-12-06 | BROWN MORGAN R | Officer | A-Award | A | Stock Option (Right to Buy) | 75,000 | 3.52 | 264.0K | 75,000 | — | ↗ |
| 2017-05-12 | Higuchi John W. | Director | A-Award | A | Common Stock | 17,200 | 3.76 | 64.7K | 475,248 | — | ↗ |
| 2017-02-01 | Bass Gregory Brooks | Officer | — | D | Stock Option (Right to Buy) | 55,000 | 9.21 | 506.6K | 0 | — | ↗ |
| 2017-01-26 | Patel Mahesh V. | Director / Officer | A-Award | A | Restricted Stock Unit | 60,000 | 0.00 | — | 60,000 | — | ↗ |
| 2017-01-26 | Ono Richard Dana | Director | A-Award | A | Restricted Stock Unit | 7,000 | 0.00 | — | 7,000 | — | ↗ |
| 2017-01-26 | Mattila Jyrki | Officer | A-Award | A | Restricted Stock Unit | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2017-01-26 | Higuchi John W. | Director | A-Award | A | Restricted Stock Unit | 5,000 | 0.00 | — | 5,000 | — | ↗ |
| 2017-01-26 | HILL STEPHEN A | Director | A-Award | A | Restricted Stock Unit | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2017-01-26 | Fink Jeffrey Arvin | Director | A-Award | A | Restricted Stock Unit | 7,500 | 0.00 | — | 7,500 | — | ↗ |
| 2017-01-26 | BROWN MORGAN R | Officer | A-Award | A | Restricted Stock Unit | 37,500 | 0.00 | — | 37,500 | — | ↗ |
| 2016-12-07 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 140,000 | 3.61 | 505.4K | 140,000 | — | ↗ |
| 2016-12-07 | Mattila Jyrki | Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 3.61 | 144.4K | 40,000 | — | ↗ |
| 2016-12-07 | BROWN MORGAN R | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.61 | 180.5K | 50,000 | — | ↗ |
| 2016-06-14 | Ono Richard Dana | Director | A-Award | A | Common Stock (right to buy) | 10,000 | 8.02 | 80.2K | 10,000 | — | ↗ |
| 2016-06-14 | Higuchi John W. | Director | A-Award | A | Common Stock (right to buy) | 10,000 | 8.02 | 80.2K | 10,000 | — | ↗ |
| 2016-06-14 | HILL STEPHEN A | Director | A-Award | A | Common Stock (right to buy) | 10,000 | 8.02 | 80.2K | 10,000 | — | ↗ |
| 2016-06-14 | Fink Jeffrey Arvin | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 8.02 | 80.2K | 10,000 | — | ↗ |
| 2016-01-05 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 140,000 | 12.92 | 1.81M | 140,000 | — | ↗ |
| 2016-01-05 | Mattila Jyrki | Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 12.92 | 516.8K | 40,000 | — | ↗ |
| 2016-01-05 | BROWN MORGAN R | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 12.92 | 646.0K | 50,000 | — | ↗ |
| 2015-09-30 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 12.00 | 24.0K | 885,632 | — | ↗ |
| 2015-09-30 | Higuchi John W. | Director | P-Purchase | A | Common Stock | 5,000 | 12.68 | 63.4K | 693,382 | — | ↗ |
| 2015-06-16 | Ono Richard Dana | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 7.29 | 145.8K | 30,000 | — | ↗ |
| 2015-06-16 | Higuchi John W. | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 7.29 | 145.8K | 201,490 | — | ↗ |
| 2015-06-16 | HILL STEPHEN A | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 7.29 | 145.8K | 30,000 | — | ↗ |
| 2015-06-16 | Fink Jeffrey Arvin | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 7.29 | 145.8K | 30,000 | — | ↗ |
| 2015-06-11 | Mattila Jyrki | Officer | A-Award | A | Stock Option (Right to Buy) | 10,000 | 7.32 | 73.2K | 90,000 | — | ↗ |
| 2015-05-15 | Mattila Jyrki | Officer | A-Award | A | Stock Option (Right to Buy) | 80,000 | 7.66 | 612.8K | 80,000 | — | ↗ |
| 2014-11-25 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 5.10 | 10.2K | 885,632 | — | ↗ |
| 2014-11-24 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 5.45 | 10.9K | 883,632 | — | ↗ |
| 2014-11-19 | Ono Richard Dana | Director | P-Purchase | A | Common Stock | 4,000 | 5.14 | 20.6K | 4,000 | — | ↗ |
| 2014-11-14 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Common Stock | 100 | 5.06 | 505.99 | 881,632 | — | ↗ |
| 2014-11-13 | Patel Mahesh V. | Director / Officer | P-Purchase | A | Cmmon Stock | 2,000 | 5.05 | 10.1K | 879,632 | — | ↗ |
| 2014-11-13 | HILL STEPHEN A | Director | P-Purchase | A | Common Stock | 4,000 | 4.95 | 19.8K | 4,000 | — | ↗ |
| 2014-08-14 | Venkateshwaran Srinivasan | Officer | A-Award | A | Stock Option (Right to Buy) | 10,363 | 8.43 | 87.4K | 10,363 | — | ↗ |
| 2014-08-14 | SIMMONS GERALD T | Officer | A-Award | A | Stock Option (Right to Buy) | 11,942 | 8.43 | 100.7K | 11,942 | — | ↗ |
| 2014-08-14 | Patel Mahesh V. | Officer | A-Award | A | Stock Option (Right to Buy) | 105,116 | 8.43 | 886.1K | 105,116 | — | ↗ |
| 2014-08-14 | BROWN MORGAN R | Officer | A-Award | A | Stock Option (right to buy) | 34,268 | 8.43 | 288.9K | 34,268 | — | ↗ |
| 2014-01-06 | Ono Richard Dana | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 8.25 | 82.5K | 10,000 | — | ↗ |
| 2014-01-06 | HILL STEPHEN A | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 8.25 | 82.5K | 10,000 | — | ↗ |
| 2014-01-06 | Fink Jeffrey Arvin | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-12-10 | Venkateshwaran Srinivasan | Officer | A-Award | A | Stock Option (Right to Buy) | 7,500 | 8.10 | 60.8K | 7,500 | — | ↗ |
| 2013-12-10 | SIMMONS GERALD T | Officer | A-Award | A | Stock Option (Right to Buy) | 5,000 | 8.10 | 40.5K | 5,000 | — | ↗ |
| 2013-12-10 | Patel Mahesh V. | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 8.10 | 202.5K | 25,000 | — | ↗ |
| 2013-12-10 | Merrell Robert K. | Officer | A-Award | A | Stock Option (Right to Buy) | 4,000 | 8.10 | 32.4K | 4,000 | — | ↗ |
| 2013-12-10 | BROWN MORGAN R | Officer | A-Award | A | Restricted Stock Unit | 5,000 | 1.00 | 5.0K | 5,000 | — | ↗ |
| 2013-09-16 | BROWN MORGAN R | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 6.00 | 300.0K | 50,000 | — | ↗ |
| 2013-07-26 | VISIUM BALANCED MASTER FUND, LTD. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,206,000 | — | ↗ |
| 2013-07-24 | Venkateshwaran Srinivasan | Officer | — | D | Stock Option (Right to Buy) | 2,780 | 2.81 | 7.8K | 0 | — | ↗ |
| 2013-07-24 | UCB Manufacturing Ireland Ltd. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 580,402 | — | ↗ |
| 2013-07-24 | SIMMONS GERALD T | Officer | — | D | Common Stock | 0 | 0.00 | — | 9,649 | — | ↗ |
| 2013-07-24 | Patel Mahesh V. | Director / Officer | — | D | Stock Option (Right to Buy) | 69,518 | 2.81 | 195.3K | 0 | — | ↗ |
| 2013-07-24 | Patel Gordhan | Director / Officer | — | D | Stock Option (Right to Buy) | 41,710 | 2.81 | 117.2K | 0 | — | ↗ |
| 2013-07-24 | Merrell Robert K. | Officer | — | D | Stock Option (Right to Buy) | 6,951 | 2.81 | 19.5K | 0 | — | ↗ |
| 2013-07-24 | Higuchi John W. | Director | — | D | Common Stock | 0 | 0.00 | — | 303,048 | — | ↗ |
| 2013-07-24 | HIGUCHI WILLIAM I | Director | — | D | Common Stock | 0 | 0.00 | — | 891,876 | — | ↗ |
| 2013-07-24 | ELAN CORP PLC | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 800,394 | — | ↗ |
| 2012-02-12 | VIZEL ISRAEL MENAHEM | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,000,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-6.5K
Shares Outstanding
5.45M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | President and Chief Executive Officer | 584.8K | — | — | 89.4K | 292.4K | 19.8K | 986.3K | 9.07% | ↗ |
| 2 | 2025 | Senior Vice President, Research and Development | 331.2K | — | — | 69.8K | 115.9K | 14.0K | 530.9K | 13.14% | ↗ |
| 3 | 2025 | Principal Accounting Officer and Corporate Controller | 275.3K | — | — | 62.2K | 96.4K | 12.1K | 446.0K | 13.94% | ↗ |
| 4 | 2024 | President and Chief Executive Officer | 565.0K | — | 53.0K | 39.6K | 84.8K | 19.4K | 761.8K | 12.16% | ↗ |
| 5 | 2024 | Senior Vice President, Research and Development | 320.0K | — | 14.8K | 31.6K | 33.6K | 13.8K | 413.8K | 11.21% | ↗ |
| 6 | 2024 | Principal Accounting Officer and Corporate Controller | 266.0K | — | 10.7K | 22.8K | 27.9K | 13.1K | 340.6K | 9.85% | ↗ |
| 7 | 2023 | President and Chief Executive Officer | 525.0K | — | — | 97.8K | 218.8K | 18.8K | 860.3K | 11.37% | ↗ |
| 8 | 2023 | Senior Vice President, Research and Development | 298.0K | — | — | — | 74.5K | 13.2K | 385.7K | 0.00% | ↗ |
| 9 | 2023 | Principal Accounting Officer and Corporate Controller | 248.0K | — | — | — | 62.0K | 11.1K | 321.1K | 0.00% | ↗ |
| 10 | 2022 | President and Chief Executive Officer | 494.2K | — | — | 284.9K | 89.0K | 15.8K | 883.9K | 32.24% | ↗ |
| 11 | 2022 | Senior Vice President, Research and Development | 265.7K | — | — | 41.0K | 33.2K | 12.2K | 352.2K | 11.65% | ↗ |
| 12 | 2022 | Principal Accounting Officer and Corporate Controller | 229.3K | — | — | 29.7K | 28.7K | 10.2K | 297.8K | 9.96% | ↗ |
| 13 | 2018 | President, Chief Executive Officer and Chairman of the Board | 439.4K | 118.6K | 423.4K | 157.8K | — | 14.3K | 1.15M | 50.39% | ↗ |
| 14 | 2018 | Executive Vice President and Chief | 325.0K | 68.3K | 167.9K | 78.9K | — | 11.0K | 651.0K | 37.91% | ↗ |
| 15 | 2018 | Vice President, Product Development | 234.0K | 30.9K | 131.4K | 35.8K | — | 11.0K | 443.0K | 37.73% | ↗ |
| 16 | 2017 | President, Chief Executive Officer and Chairman of the Board | 435.0K | 231.0K | 216.6K | 363.0K | — | 13.0K | 1.26M | 46.05% | ↗ |
| 17 | 2017 | Executive Vice President and Chief Commercial Officer | 365.6K | 201.0K | 135.4K | 181.5K | — | 10.8K | 894.2K | 35.44% | ↗ |
| 18 | 2017 | Executive Vice President and Chief Financial Officer | 305.0K | 126.0K | 135.4K | 181.5K | — | 10.8K | 758.7K | 41.77% | ↗ |
| 19 | 2017 | Executive Vice President and Chief | 305.0K | 126.0K | 135.4K | 181.5K | — | 10.8K | 758.7K | 41.77% | ↗ |
| 20 | 2017 | Vice President, Marketing and Sales Operations | 219.1K | 110.5K | — | 219.4K | — | 7.8K | 556.8K | 39.41% | ↗ |
| 21 | 2017 | Vice President, Product Development | 216.7K | 56.2K | 108.3K | 82.3K | — | 8.7K | 472.2K | 40.36% | ↗ |
| 22 | 2016 | Mahesh V. Patel President, Chief Executive Officer and Chairman of the Board of Directors | 435.0K | 191.0K | — | 1.63M | — | 12.7K | 2.27M | 71.87% | ↗ |
| 23 | 2016 | President, Chief Executive Officer and Chairman of the Board | 435.0K | 7.0K | — | 1.63M | — | 12.7K | 2.09M | 78.21% | ↗ |
| 24 | 2016 | Morgan R. Brown Executive Vice President and Chief Financial Officer | 305.0K | 104.6K | — | 582.8K | — | 10.6K | 1.00M | 58.10% | ↗ |
| 25 | 2016 | Executive Vice President and Chief Financial Officer | 305.0K | 7.0K | — | 582.8K | — | 10.6K | 905.4K | 64.37% | ↗ |
| 26 | 2016 | Jyrki Mattila Executive Vice President and Chief Business Officer | 338.0K | 88.5K | — | 466.2K | — | 10.6K | 903.3K | 51.61% | ↗ |
| 27 | 2016 | Executive Vice President and Chief Commercial Officer | 305.3K | 72.0K | — | 444.2K | — | 10.6K | 832.0K | 53.39% | ↗ |
| 28 | 2016 | Vice President, Product Development | 216.7K | 7.0K | — | 304.5K | — | 7.9K | 536.1K | 56.80% | ↗ |
| 29 | 2016 | Vice President, Marketing and Sales Operations | — | — | — | — | — | — | — | — | ↗ |
| 30 | 2015 | Jyrki Mattila Executive Vice President and Chief Business Officer | 202.5K | 75.0K | — | 471.0K | — | — | 748.5K | 62.93% | ↗ |
| 31 | 2015 | President, Chief Executive Officer and Chairman of the Board | 400.0K | 184.0K | — | — | — | 12.7K | 596.7K | 0.00% | ↗ |
| 32 | 2015 | Mahesh V. Patel President, Chief Executive Officer and Chairman of the Board of Directors | 400.0K | 137.2K | — | — | — | 12.7K | 549.9K | 0.00% | ↗ |
| 33 | 2015 | Mahesh V. Patel, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 400.0K | 137.2K | — | — | — | 12.7K | 549.9K | 0.00% | ↗ |
| 34 | 2015 | Executive Vice President and Chief Financial Officer | 283.0K | 97.6K | — | — | — | 10.6K | 391.2K | 0.00% | ↗ |
| 35 | 2015 | Morgan R. Brown Executive Vice President and Chief Financial Officer | 283.0K | 59.9K | — | — | — | 10.6K | 353.5K | 0.00% | ↗ |
| 36 | 2015 | Vice President, Product Development | 198.8K | 40.0K | — | — | — | 8.0K | 246.7K | 0.00% | ↗ |
| 37 | 2015 | Vice President, Marketing and Sales Operations | — | — | — | — | — | — | — | — | ↗ |
| 38 | 2015 | Executive Vice President and Chief Commercial Officer | — | — | — | — | — | — | — | — | ↗ |
| 39 | 2014 | Mahesh V. Patel, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 370.8K | — | — | 585.7K | — | 9.9K | 966.4K | 60.61% | ↗ |
| 40 | 2014 | Morgan R. Brown Executive Vice President and Chief Financial Officer | 263.3K | 25.0K | — | 191.0K | — | 7.7K | 487.0K | 39.21% | ↗ |
| 41 | 2014 | Gerald T. Simmons Former Corporate Business Development Officer | 191.4K | — | — | 118.2K | — | 131.7K | 441.3K | 26.79% | ↗ |
| 42 | 2014 | Jyrki Mattila Executive Vice President and Chief Business Officer | — | — | — | — | — | — | — | — | ↗ |
| 43 | 2013 | Mahesh V. Patel, Ph.D. President, Chief Executive Officer and Chairman of the Board of Directors | 320.0K | 175.0K | 81.0K | 357.0K | — | 2.0K | 935.0K | 46.84% | ↗ |
| 44 | 2013 | Mahesh V. Patel, Ph.D. President, Chief | 320.0K | 175.0K | 81.0K | 357.0K | — | 2.0K | 854.0K | 51.28% | ↗ |
| 45 | 2013 | Morgan R. Brown Executive Vice President and Chief Financial Officer | 72.9K | 25.0K | 112.5K | 249.8K | — | — | 460.2K | 78.72% | ↗ |
| 46 | 2013 | Srinivasan Venkateshwaran, Ph.D. Chief Technology Officer and Vice President of Research and Development | 213.5K | 35.0K | — | 78.0K | — | — | 326.6K | 23.89% | ↗ |
| 47 | 2013 | Gerald T. Simmons Former Corporate Business Development Officer | 188.2K | 35.0K | — | 59.9K | — | — | 283.1K | 21.15% | ↗ |
| 48 | 2013 | Gerald T. Simmons Corporate Business Development Officer | 188.2K | 35.0K | — | 59.9K | — | — | 283.1K | 21.15% | ↗ |
| 49 | 2012 | Mahesh V. Patel, Ph.D. President, Chief | 300.0K | — | — | — | — | 1.3K | 301.3K | 0.00% | ↗ |
| 50 | 2012 | Srinivasan Venkateshwaran, Ph.D. Chief Technology Officer and Vice President of Research and Development | 205.0K | — | — | — | — | — | 205.0K | 0.00% | ↗ |
| 51 | 2012 | Gerald T. Simmons Corporate Business Development Officer | 181.0K | — | — | — | — | — | 181.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mahesh V. Patel | Co-Founder, President, CEO & Director | 896.9K | — |
| Nachiappan Chidambaram | Senior Vice President of Research & Development | 461.1K | male |
| Logan Morse | Vice President of Sales, Marketing & Operations | 413.6K | male |
| Krista Fogarty | Principal Accounting Officer & Corporation Controller | 383.8K | female |
| Anthony DelConte D. | Chief Medical Director | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LPCN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
